Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia

[1]  Prabhakar R. Gudla,et al.  Dynamic imaging of nascent RNA reveals general principles of transcription dynamics and stochastic splice site selection , 2021, Cell.

[2]  A. Bergman,et al.  Single Molecule Imaging of Transcription Dynamics in Somatic Stem Cells , 2020, Nature.

[3]  Jinlan Pan,et al.  High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia , 2019, Journal of cellular physiology.

[4]  Michael G. Kharas,et al.  RNA Regulators in Leukemia and Lymphoma. , 2019, Cold Spring Harbor perspectives in medicine.

[5]  Robert M Vernon,et al.  First-generation predictors of biological protein phase separation. , 2019, Current opinion in structural biology.

[6]  Hailing Shi,et al.  Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG. , 2019, Molecular cell.

[7]  Michael Q. Zhang,et al.  Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription , 2019, Cell.

[8]  D. Elliott,et al.  RBMX family proteins connect the fields of nuclear RNA processing, disease and sex chromosome biology. , 2019, The international journal of biochemistry & cell biology.

[9]  A. Krainer,et al.  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. , 2019, Cancer cell.

[10]  Michael G. Kharas,et al.  IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation. , 2019, Cell stem cell.

[11]  R. Vernon,et al.  RGG/RG Motif Regions in RNA Binding and Phase Separation. , 2018, Journal of molecular biology.

[12]  Patrick J. Paddison,et al.  N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis , 2018, Nature Communications.

[13]  R. Collins,et al.  Functional genomic landscape of acute myeloid leukaemia , 2018, Nature.

[14]  Shawn C. Little,et al.  Diverse Spatial Expression Patterns Emerge from Unified Kinetics of Transcriptional Bursting , 2018, Cell.

[15]  Beth Wilmot,et al.  Functional Genomic Landscape of Acute Myeloid Leukemia , 2018, Nature.

[16]  Jacob C. Ulirsch,et al.  The NORAD lncRNA assembles a topoisomerase complex critical for genome stability , 2018, Nature.

[17]  Levi N. Naden,et al.  Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia , 2018, bioRxiv.

[18]  Guangbiao Zhou,et al.  Genomic variations in the counterpart normal controls of lung squamous cell carcinomas , 2018, Frontiers of Medicine.

[19]  Uwe Ohler,et al.  Deciphering human ribonucleoprotein regulatory networks , 2018, bioRxiv.

[20]  B. Garcia,et al.  Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes. , 2017, Molecular cell.

[21]  M. Bhasin,et al.  Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E , 2017, Oncotarget.

[22]  Francine E. Garrett-Bakelman,et al.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.

[23]  Margaret A. Goralski,et al.  Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15 , 2017, Science.

[24]  Sun Mi Park,et al.  Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells , 2017, Nature Genetics.

[25]  T. Owa,et al.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides. , 2017, Nature chemical biology.

[26]  Nian Liu,et al.  N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein , 2017, Nucleic acids research.

[27]  Eric S. Lander,et al.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.

[28]  Claude Preudhomme,et al.  A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.

[29]  Christophe Zimmer,et al.  A single-molecule view of transcription reveals convoys of RNA polymerases and multi-scale bursting , 2016, Nature Communications.

[30]  R. Paquette,et al.  Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia , 2016, Oncotarget.

[31]  Sun Mi Park,et al.  MSI2 is required for maintaining activated myelodysplastic syndrome stem cells , 2016, Nature Communications.

[32]  Elizabeth T. Wiles,et al.  Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatin , 2016, Genome research.

[33]  A. Kanagaraj,et al.  Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization , 2015, Cell.

[34]  G. Hardiman,et al.  Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia. , 2015, Cell stem cell.

[35]  C. Brangwynne,et al.  The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics , 2015, Proceedings of the National Academy of Sciences.

[36]  Timothy D. Craggs,et al.  Phase Transition of a Disordered Nuage Protein Generates Environmentally Responsive Membraneless Organelles , 2015, Molecular cell.

[37]  Pablo R. Freire,et al.  Single-cell analysis of transcription kinetics across the cell cycle , 2015, eLife.

[38]  Michael G. Kharas,et al.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. , 2015, The Journal of clinical investigation.

[39]  E. Stickeler,et al.  HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer , 2015, BMC Cancer.

[40]  E. Stickeler,et al.  HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer , 2015, BMC Cancer.

[41]  T. Cech,et al.  Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA. , 2015, Molecular cell.

[42]  Lan Lin,et al.  rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.

[43]  T. Dragani,et al.  Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients. , 2014, Lung cancer.

[44]  Brian Munsky,et al.  Transcription Factors Modulate c-Fos Transcriptional Bursts , 2014, Cell reports.

[45]  Ahmed S. Moursy,et al.  Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation , 2014, Nucleic acids research.

[46]  Jian Kong,et al.  Cytoplasmic Poly(A) Binding Protein C4 Serves a Critical Role in Erythroid Differentiation , 2014, Molecular and Cellular Biology.

[47]  T. Skorski,et al.  BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability , 2013, Leukemia.

[48]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[49]  K. Park,et al.  Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9. , 2012, Biochemical and biophysical research communications.

[50]  Richard Bonneau,et al.  The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. , 2012, Molecular cell.

[51]  Jimin Pei,et al.  Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels , 2012, Cell.

[52]  K. Fukui,et al.  RBMX: a regulator for maintenance and centromeric protection of sister chromatid cohesion. , 2012, Cell reports.

[53]  J. Kutok,et al.  MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia. , 2011, Blood.

[54]  P. Potter,et al.  Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing. , 2011, ACS chemical biology.

[55]  Markus Jäger,et al.  Expression levels of hnRNP G and hTra2‐beta1 correlate with opposite outcomes in endometrial cancer biology , 2011, International journal of cancer.

[56]  Stefan Stamm,et al.  Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1 , 2011, Nature Structural &Molecular Biology.

[57]  T. Petrella,et al.  Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Côte d’Or (Burgundy, France) , 2011, Haematologica.

[58]  Fatima Al-Shahrour,et al.  Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia , 2010, Nature Medicine.

[59]  Takahiro Ito,et al.  Regulation of myeloid leukemia by the cell fate determinant Musashi , 2010, Nature.

[60]  L. Shih,et al.  Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes. , 2010, Leukemia research.

[61]  M. Penrad-Mobayed,et al.  Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts , 2010, Nucleus.

[62]  A. Hartmann,et al.  Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA* , 2009, Journal of Biological Chemistry.

[63]  Lifeng Tian,et al.  The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. , 2009, Cancer research.

[64]  Howard Y. Chang,et al.  Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. , 2009, Cell stem cell.

[65]  J. Workman,et al.  The heterochromatin protein 1 (HP1) family: put away a bias toward HP1. , 2008, Molecules and cells.

[66]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[67]  M. Hagiwara,et al.  Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA , 2007, Nature Chemical Biology.

[68]  T. Owa,et al.  Splicing factor SF3b as a target of the antitumor natural product pladienolide , 2007, Nature Chemical Biology.

[69]  Anping Li,et al.  Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. , 2007, Molecular biology of the cell.

[70]  Ki-Hyuk Shin,et al.  Heterogeneous Nuclear Ribonucleoprotein G Shows Tumor Suppressive Effect against Oral Squamous Cell Carcinoma Cells , 2006, Clinical Cancer Research.

[71]  Marina Pollán,et al.  Positive correlation between the expression of X‐chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer , 2006, Journal of cellular biochemistry.

[72]  Hongyue Dai,et al.  Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Almouzni,et al.  HP1 and the dynamics of heterochromatin maintenance , 2004, Nature Reviews Molecular Cell Biology.

[74]  I. Eperon,et al.  HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. , 2003, Human molecular genetics.

[75]  J. Taub,et al.  Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines. , 2003, Blood.

[76]  Y. Ravindranath,et al.  High frequency of the 844ins68 cystathionine-β-synthase gene variant in Down syndrome children with acute myeloid leukemia , 2002, Leukemia.

[77]  C. Disteche,et al.  Expression and conservation of processed copies of the RBMX gene , 2001, Mammalian Genome.

[78]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[79]  F S Fay,et al.  Visualization of single RNA transcripts in situ. , 1998, Science.

[80]  F. Alt,et al.  Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. , 1994, Science.